Pharmacogenomics of phase II metabolizing enzymes and drug transporters: clinical implications
{{output}}
The clinical impact of pharmacogenomics remains a hot topic of current research efforts. Although pharmacogenomics of phase I metabolizing enzymes seems to have been well studied, knowledge on the clinical impact of genetic variability of phase II metabolizing... ...
